Clinical relevance of penicillin-resistant Streptococcus pneumoniae, with particular attention to therapy with ceftizoxime, cefotaxime, and ceftriaxone

Infectious Diseases in Clinical Practice

Volumn 5, Issue SUPPL. 1, 1996, Pages

  Quintiliani, Richard ^a   Nicolau, David P ^a   Nightingale, Charles H ^a  

^a HARTFORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM ANTIBIOTIC; CEFAZOLIN; CEFOTAXIME; CEFTIZOXIME; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN; ERYTHROMYCIN; PENICILLIN G; VANCOMYCIN;

CONFERENCE PAPER; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NONHUMAN; PENICILLIN RESISTANCE; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE;

EID: 0029920433     PISSN: 10569103     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Simberkoff S. Drug-resistant pneumococcal infections in the United States. JAMA 1994;271:1875-6.
2. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 1994;14:(No. 16).
3. Thornsberry C. The activity of ceftizoxime, cefotaxime and ceftriaxone against recent (1995) isolates of Streptococcus pneumoniae: correlation with penicillin resistance. Franklin (TN): MRL Pharmaceutical Services, 1995.
4. Craig WA. Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalosporins. Diagn Microbiol Infect Dis 1995;22:89-96.
5. Knudsen DJ, Frimodt-Moller, Espersen F. Experimental streptococcus pneumonial infection in mice for studying correlation of in vitro and in vivo activities of penicillin against pneumococci with various susceptibilities to penicillin. Antimicrob Agents Chemother 1995;39:1253-8.
6. Patel KB, Nicolau DP, Nightingale CH, Quintiliani R. Comparative serum bactericidal activity of ceftizoxime and cefotaxime against intermediate penicillin-resistant Streptococcus pneumoniae. Proceedings of the 35th International Conference of Antimicrobial Agents and Chemotherapy; Sept 18-20, 1995; San Francisco (CA). Washington (DC): American Society for Microbiology, 1995.
7. Belliveau PP, Freeman CD, Nicolau DP, Nightingale CH, Tessier PR, Quintiliani R. Bactericidal activity of ceftizoxime and ceftriaxone vs. pathogens of community-acquired and nosocomial pneumonia. In press.
8. Stratton CW, Aldridge KE, Gelfand MS. In-vitro killing of penicillin-susceptible, -intermediate, and -resistant strains of Streptococcus pneumoniae by cefotaxime, ceftriaxone, and cepizoxime: a comparison of bactericidal and inhibitory activity with achievable CSF levels. Diagn Microbiol Infect Dis 1995;22:35-42.
9. Haas DW, Stratton CW, Griffin JP, Weeks L, Alls SC. Diminished activity of ceftizoxime in comparison to cefotaxime and ceftriaxone against Streptococcus pneumoniae. Clin Infect Dis 1995;20:671-6.
10. Pallares R, Gudiol F, Linares J, et al. Risk factors and response to antibiotic therapy with bacteremic pneumonia caused by penicillin-resistant pneumococci. N Engl J Med 1987;317:18-22.
11. Klugman KP. Management of antibiotic-resistant pneumococcal infections. J Antimicrob Chemother 1994;34: 191-3.
12. Austrian R, Gold J. Pneumococcal bacteremia with special reference to bacteremic pneumococcal pneumonia. Ann Intern Med 1964;60:759-76.
13. Pallares R, Linares J, Vadillo M, et al. Resistance to penicillin and cephalosporins and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N Engl J Med 1995;333:474-80.
14. Reves RR, Jones JA. Antibiotic use and resistance patterns in day care centers. Semin Pediatr Infect Dis 1990;1: 212-21.
15. Centers for Disease Control. Drug-resistant Streptococcus pneumoniae - Kentucky and Tennessee. MMWR Morb Mortal Wkly Rep 1993;43:23-31.
16. Bradley JS, Connor JD. Ceftriaxone failure in meningitis caused by Streptococcus pneumoniae with reduced susceptibility to β-lactam antibiotics. Pediatr Infect Dis 1991; 10:871-3.
17. Sloas MM, Barrett FF, Chesney PJ, et al. Cephalosporin treatment failure in penicillin and cephalosporin-resistant Streptococcus pneumoniae meningitis. Pediatr Infect Dis 1992;11:662-6.
18. Kleiman MB, Weinberg GA, Reynolds JK, Allen SD. Meningitis with β-lactam-resistant Streptococcus pneumoniae. the need for early repeat lumbar puncture. Pediatr Infect Dis 1993;12:782-4.
19. Friedland IR, Shelton S, Paris M, et al. Dilemmas in diagnosis and management of cephalosporin-resistant Streptococcus pneumoniae meningitis. Pediatr Infect Dis J 1993;12:196-200.
20. McCracken GH Jr, Sakata Y. Antimicrobial therapy of experimental meningitis caused by Streptococcus pneumoniae strains with different susceptibilities to penicillin. Antimicrob Agents Chemother 1985;27:141-5.
21. Viladrich PF, Gudol F, Linares J, Rufi G, Ariza J, Pallares R. Characteristics antibiotic therapy of adult meningitis due to penicillin-resistant pneumococci. Am J Med 1988; 84:839-46.